Skip to main content
NeuPath Health Inc. logo

NeuPath Health Inc. — Investor Relations & Filings

Ticker · NPTH TSXV Human health and social work activities
Open in API
Filings indexed 182 across all filing types
Latest filing 2026-04-09 Regulatory Filings
Country CA Canada
Listing TSXV NPTH

About NeuPath Health Inc.

https://neupath.com/

NeuPath Health Inc. is an integrated healthcare provider specializing in chronic pain management and musculoskeletal (MSK) care. The company operates a network of clinics offering comprehensive assessments and rehabilitation services. NeuPath utilizes a vertically integrated, interdisciplinary approach, leveraging research, data-driven insights, and technology to develop patient-centered, tailored treatment plans. Services address a range of conditions including acute and chronic pain, spinal injuries, sports-related injuries, and concussions. The company is also noted for providing innovative treatments, such as Arthrosamid, for conditions like knee osteoarthritis.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a press release announcing NeuPath Health’s CEO will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference. It does not contain actual financial results, slide decks, an earnings summary, nor detailed presentation materials. It is simply a corporate announcement of an upcoming investor event. This does not fit into categories like 10-K, IR, ER, IP (actual presentation), or PSI. Therefore, the best fit is the general “Regulatory Filings” fallback category (RNS).
2026-04-09 English
News release - English.pdf
Investor Presentation Classification · 1% confidence The document is a press release announcing that NeuPath Health’s CEO will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference, including webcast details. It is not an earnings release or regulatory report, but rather an announcement of an upcoming investor presentation event. Therefore, it best fits the ‘Investor Presentation’ category.
2026-04-09 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a corporate press release announcing that NeuPath Health will issue 893,616 common shares to settle $420,000 of indebtedness to insiders (the former CEO and the CFO). It details the terms of the debt settlement, related party transaction exemptions, required shareholder approval, and hold periods. There is no detailed financial report or earnings numbers beyond background, nor is it a regulatory form attachment notice. Instead, it is clearly an announcement of a new share issuance for capital change (debt-for-equity). This fits the definition of Share Issue/Capital Change (SHA).
2026-04-01 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a news release announcing that NeuPath Health Inc. will issue common shares to settle indebtedness owed to the CEO and CFO. This constitutes a corporate capital structure change by issuing new shares (related party transaction under MI 61-101). It is not an earnings release, management change, or annual/interim report, but rather an announcement of share issuance. Accordingly, the most appropriate category is Share Issue/Capital Change (SHA).
2026-04-01 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a corporate news release announcing the issuance of 893,616 common shares to settle indebtedness owed to two insiders. It details the share issuance price, hold periods, regulatory exemptions, and upcoming shareholder approval at the annual meeting. This constitutes an announcement of a new share issue and a capital structure change rather than an earnings release, management discussion, or regulatory attachment. Therefore, the appropriate category is Share Issue/Capital Change (SHA).
2026-04-01 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release from NeuPath Health Inc. announcing two primary items: executive leadership changes (CEO transition and new CIO appointment) and preliminary financial results for the 2025 fiscal year. While it contains financial data, it is an announcement of preliminary results rather than a full financial report, and it explicitly covers management changes. Given the dual nature, 'MANG' (Board/Management Information) is the most accurate classification as it covers the leadership transition, which is a primary focus of the headline and the body text. FY 2025
2026-01-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.